Catarina L. Ferreira

Dr. Catarina L. Ferreira

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
JVJoana Viegas
Joana Viegas
Elsa Maria CardosoElsa Maria Cardoso
Elsa Maria Cardoso
LBLucile Bonneau
Lucile Bonneau
AEAna Filipa Esteves
Ana Filipa Esteves
CFCatarina L. Ferreira
Catarina L. Ferreira
LTLuis Taborda-Barata
Luis Taborda-Barata
Sulfurous thermal waters (STWs) are used as a complementary treatment for allergic rhinitis. However, there is scant data on the effects of STW on nasal epithelial cells, and in vitro models are warranted. The main aim of this study was to evaluate the dose and time effects of exposure to 3D nasal inserts (MucilAirTM-HF allergic rhinitis model) with STW or isotonic sodium chloride solution (ISCS) aerosols. Transepithelial electrical resistance (TEER) and histology were assessed before and after nebulizations. Chemokine/cytokine levels in the basal supernatants were assessed by enzyme-linked immunosorbent assay. The results showed that more than four daily nebulizations of four or more minutes compromised the normal epithelial integrity. In contrast, 1 or 2 min of STW or ISCS nebulizations had no toxic effect up to 3 days. No statistically significant changes in release of inflammatory chemokines MCP-1/CCL2 > IL-8/CXCL8 > MIP-1α/CCL3, no meaningful release of “alarmins” (IL-1α, IL-33), nor of anti-inflammatory IL-10 cytokine were observed. We have characterized safe time and dose conditions for aerosol nebulizations using a novel in vitro 3D nasal epithelium model of allergic rhinitis patients. This may be a suitable in vitro setup to mimic in vivo treatments of chronic rhinitis with STW upon triggering an inflammatory stimulus in the future.

27 June 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
ACAna R. Costa
Ana R. Costa
ADAna Catarina Duarte
Ana Catarina Duarte
IGIsabel Goncalves
Isabel Goncalves
CFCatarina L. Ferreira
Catarina L. Ferreira
ECEduardo Brites Cavaco
Eduardo Brites Cavaco
Cecília R. SantosCecília R. Santos
Cecília R. Santos
Glioblastoma is the most common and aggressive form of primary brain cancer. Despite significant progress in the development of promising therapeutic agents, cancer-targeting therapies often fail to achieve effective concentrations in the brain, limiting their therapeutic efficacy. As such, a deeper understanding of how glioblastoma tumours interact with their microenvironment and assess the chemical composition therein can reveal novel therapeutic strategies. Recent studies have highlighted the critical role of taste receptors, particularly bitter taste receptors (TAS2Rs) and their ligands in cancer progression and metastasis. Activation of TAS2Rs by both natural and synthetic compounds has been associated with drug resistance, apoptosis, and the proliferation of malignant tumours. The sweet taste receptor TAS1R2/TAS1R3, or the umami receptor TAS1R1/TAS1R3, as recognised sensors of glucose levels and aminoacids, respectively, are also of interest in the context of cancer metabolism. In this study, we investigated the expression and function of TAS2Rs, TAS1R2/TAS1R3 and TAS1R1/TAS1R3 and all the taste signalling pathway machinery in glioblastoma. Our findings demonstrate that TAS1R2/TAS1R3, TAS1R1/TAS1R3, and 20 out of the 26 human TAS2Rs are present and active in glioblastoma cells, with expression differences in glioblastoma cells and human tumours. The expression of such a large number of members of this family of receptors, highlight the significance of the taste transduction pathway in this form of brain cancer, where these receptors might be essential for the crosstalk between glioblastoma and its microenvironment.

29 June 2024 in Cancers
Verified
Journal Article
Open access
PDF file
Micaela AlmeidaMicaela Almeida
Micaela Almeida
CFCatarina L. Ferreira
Catarina L. Ferreira
RTRosa Maria Tomé
Rosa Maria Tomé
JFJosé Fonseca-Moutinho
José Fonseca-Moutinho
APAntónio Polónia
António Polónia
LBLuiza Breitenfeld
Luiza Breitenfeld
Breast cancer remains the leading cause of cancer deaths for women. Long-term estrogen exposure is considered carcinogenic due to semiquinone production and to compromised detoxification. Metabolic regulator polymorphisms, such as KEAP1 (rs1048290) and NRF2 (rs35652124, rs6721961, rs6706649), can be valuable in understanding the individual cytoprotection profile. Thus, we aim to genotype these polymorphisms in blood, tumours and surrounding tissue, to identify somatic mutations and correlate it to prognoses. A total of 23 controls and 69 women with histological confirmed breast cancer were recruited, and DNA from blood/surrounding/tumour tissue was genotyped. Genotyping and clinicopathological data were correlated. We verified that rs35652124 presents different genotype distribution between the blood/surrounding tissue (p-value = 0.023) and tumour/surrounding tissues (p-value = 0.041). Apart from rs35652124 and considering the histological grade, the other four polymorphisms have different distributions among different tissues. There is a tendency towards the loss of heterozygosity in the surrounding tissue when compared to blood and tumour tissues, and higher genotype variability in histologic grade 2. These somatic mutations and different distribution patterns may indicate a heterogeneous and active microenvironment, influencing breast cancer outcome. Additionally, it would be pertinent to evaluate the predictive value of the histologic grade 2 considering somatic mutation profiles and distributions.

23 February 2017
Verified
Conference Paper
Closed access
CFCatarina L. Ferreira
Catarina L. Ferreira

28 May 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Telma QuintelaTelma Quintela
Telma Quintela
ADAna Catarina Duarte
Ana Catarina Duarte
FPFilipa Patriarca
Filipa Patriarca
RMRafael Mineiro
Rafael Mineiro
TATânia Cristina de Oliveira Albuquerque
Tânia Cristina de Oliveira Albuquerque
Cecília R. SantosCecília R. Santos
Cecília R. Santos
Neurosteroids are important regulators of numerous central nervous system (CNS) functions, playing essential roles in protecting the brain from insults such as neurodegeneration or ischemia. The choroid plexus (CP) epithelial cells establish an important physical interface between the peripheral blood and the cerebrospinal fluid (CSF), the Blood-CSF barrier (BCSFB), contributing to CNS homeostasis. There is evidence that the BCSFB is a target of sex steroid hormones, which regulate the expression of neuroprotective proteins. In contrast to other brain regions, little is known regarding the production of neurosteroids in the CP. Previously, a cDNA microarray analysis of the CP transcriptome showed the expression of several enzymes involved in steroidogenesis. We, therefore, investigated whether the key steroidogenic enzymes P450scc, P450aro, 17βHSD3, 17βHSD8, 5α-reductase 1, and 5α-reductase 2 are present in the rat and human CP. The present study demonstrates mRNA and protein expression of these enzymes in rat and human CP. Collectively the present data suggest that neurosteroids can be synthesised at the BCSFB and released into the CSF contributing to brain neuroprotection.